Researchers have published the outcomes of the TB-PRACTECAL clinical trial, which assessed the effectiveness and safety of oral bedaquiline, linezolid, and pretomanid-based regimens for treating rifampicin-resistant pulmonary tuberculosis.
In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, and pretomanid (BPaL)-based regimens for pulmonary tuberculosis resistant to rifampicin.
TB-PRACTECAL Clinical Trial Tuberculosis Rifampicin-Resistant Bedaquiline Linezolid Pretomanid
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Adjunctive Tongxinluo therapy aids ST-segment elevation myocardial infarction outcomes: StudyIn patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy to guideline-directed treatment, is associated with significantly improved clinical outcomes, according to a study published in the Oct. 24/31 issue of the Journal of the American Medical Association.
続きを読む »
Study improves outcomes for patients undergoing chest wall surgeryA faculty member and group of students from the University of New England College of Osteopathic Medicine (UNE COM) published a study earlier this year with findings that may help relieve pain in pediatric patients following surgery to the chest.
続きを読む »
Study finds TNF blockers are not associated with poor pregnancy outcomesAccording to new research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, continuing tumor necrosis factor inhibitors during pregnancy is not associated with worse fetal or obstetric outcomes and may reduce the risk of severe maternal infections during pregnancy.
続きを読む »
Does guideline-based treatment prevent racial disparities in cardiovascular outcomes?Cardiovascular disease remains the leading cause of death for women within most racial and ethnic groups in the United States.
続きを読む »
Newly identified amino acid may play key role in predicting outcomes and treatment of long COVIDUniversity of Alberta researchers have identified an amino acid that may play a key role in predicting poor clinical outcomes and the treatment of long COVID.
続きを読む »
TAVR and Watchman procedures together yield similar outcomes to blood thinners after TAVR for atrial fibrillationFindings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage occlusion (LAAO) procedure using the Watchman device had similar outcomes as patients getting TAVR in addition to medical therapy or blood thinners.
続きを読む »